kras mutation and glutathion

kras mutation and glutathion G12V mutation-selective requirement for ACSS2 in colorectal adenoma formation: Cell Reports Uncovering new therapeutic targets for

Name: kras mutation and glutathion G12V mutation-selective requirement for ACSS2 in colorectal adenoma formation: Cell Reports Uncovering new therapeutic targets for
Brand: creatorsinfotech.com
SKU: 77048767325
Price: 23.11 USD
Availability: InStock
Rating: 4.6318 (17 reviews)

Uncovering new therapeutic targets for a common KRAS mutation behind cancer Selective killing of cancer cells harboring mutant RAS by concomitant inhibition of NADPH oxidase and glutathione biosynthesis Cell Death & Disease Metabolic networks in mutant KRAS driven tumours: tissue specificities and the microenvironment Nature Reviews Cancer Rerouting the drug response: Overcoming metabolic adaptation in KRAS mutant cancers Science Signaling Kinetic and Redox Characterization of KRAS G12C Inhibition bioRxiv

SKU: 77048767325 · From creatorsinfotech.com

4.6

USD23.11 USD54.11

Pay in 4 interest-free payments of $5.78 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Oct 27 - Nov 1

Description

Reduced glutathione (GSH) occurs naturally in all human cells

Cancer Communications , 43 (7), 788807

Millimolar concentrations of ascorbic acid in purified human mononuclear leukocytes

We further summarize therapeutic agents under development that target glucose, lipid, and amino acid metabolism in cancer

however, deletion of BDs eliminated these interactions, indicating that BRD4 ET does not appreciably contribute to the association of BRD4 with the enhancer-derived or coding RNAs